Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ceres Pharma is a dynamic Belgian pharmaceutical company focused on the development and distribution of high-quality medicines, medical devices, and food supplements. The company has established a significant presence in Italy through the strategic acquisitions of Amnol Pharma and Kito Pharma, integrating their portfolios into a broader European network. Ceres Pharma Italy specializes in niche therapeutic areas including Women's Health, Pediatrics, and specialized nutrition. Their business model combines the commercialization of proprietary brands with the distribution of partnered products across the Italian pharmacy and hospital channels. The company is backed by private equity firm Nexicap Partners, supporting its aggressive buy-and-build strategy across Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ceres Pharma Italy.